IMM-H004 attenuates neutrophil pyroptosis following ischemic stroke via a CKLF1 dependent mechanism

Key Points

• Neutrophil pyroptosis is significantly reduced with IMM-H004 treatment, indicating its potential efficacy.
• The study observes a notable reduction in pyroptosis with a focus on the CKLF1 pathway during ischemic conditions.
• Analysis reveals the involvement of CKLF1 as a central mechanism in the response to ischemic stroke.
• Findings support further exploration of IMM-H004 as a therapeutic option in stroke management.